| Patent application number | Description | Published |
|---|
| 20080216027 | Electronic Design for Integrated Circuits Based on Process Related Variations - An electronic design is generated for an integrated circuit that is to be fabricated in accordance with the electronic design by a process that will impart topographically induced feature dimension variations to the integrated circuit. The generating includes adjusting the electronic design based on predictions of topographical and topographical-related feature dimension variations by a pattern-dependent model. An RC extraction tool is used in conjunction with the generating and adjusting of the electronic design. The process includes a fabrication process that will impart topographical variation to the integrated circuit and a lithography or etch process. Placement attributes for elements of the integrated circuit are determined. | 09-04-2008 |
| 20090031271 | ROBUST DESIGN USING MANUFACTURABILITY MODELS - The present invention allows for a robust design using manufacturability models. A method, system and/or computer usable medium may be provided in an integrated circuit design to track sensitivity to a variation of process from wafer to wafer and/or fab to fab in order to assist the designers to anticipate the variations to improve the final yield of the products. | 01-29-2009 |
| 20090199139 | METHOD, SYSTEM, AND COMPUTER PROGRAM PRODUCT FOR IMPROVED ELECTRICAL ANALYSIS - An improved method, system, user interface, and computer program product is described for using a memory and learning component to improve capacitance and resistance estimates based on the types of layouts and devices being evaluated. According to some approaches, a learning component is implemented that uses recommended test sets from the evaluation component to automatically test the extraction estimates against the field solver. Variability models from manufacturing or electrical analysis may also be used to select a series of objects (unique conductor geometries) that make up a conduction path or net or specific conductor geometries for evaluation and additional learning improvement. | 08-06-2009 |
| 20110046767 | METHOD, SYSTEM, AND COMPUTER PROGRAM PRODUCT FOR PREPARING MULTIPLE LAYERS OF SEMICONDUCTOR SUBSTRATES FOR ELECTRONIC DESIGNS - Disclosed is an improved method, system, and computer program product for preparing multiple levels of semiconductor substrates for three-dimensional IC integration. Some embodiments utilize the process and design models to check and fabricate the insulating dielectric layer (IDL) separating the first and the second film stacks on separate substrates and then prepare the surface of the IDL to receive an additional layer of semiconductor substrate for further fabrication of the chips. Yet some other embodiments further employ the design and process models to ensure the IDL and the semiconductor substrate are sufficiently flat, or are otherwise satisfactory, so the three-dimensional integrated circuits meet the reliability, manufacturability, yield, or performance requirements. Yet some other embodiments further employ design and process models to place the vias connecting the multiple film stacks. | 02-24-2011 |
| 20110093826 | METHOD AND SYSTEM FOR MODEL-BASED ROUTING OF AN INTEGRATED CIRCUIT - Disclosed is a method, system, and computer program product for implementing model-based floorplanning, layout, placement, and routing. Models are used to guide the placement and routing of polygons on the IC layout based upon predictions of manufacturing variations. | 04-21-2011 |
| Patent application number | Description | Published |
|---|
| 20080255501 | PERCUTANEOUS DELIVERY AND RETRIEVAL SYSTEMS FOR SHAPE-CHANGING ORTHOPEDIC JOINT DEVICES - Delivery and retrieval systems for delivering or retrieving a shape-changing percutaneously implantable orthopedic device joint prosthesis that can move between a generally arcuate configuration and a substantially straightened or slightly curved configuration. The orthopedic device can be delivered with a needle that is joint expanding, actuating, pivotable, or can include a balloon. The orthopedic device acts as a soft compliant bearing surface or cushion that minimizes the bone-on-bone wear from articulation and loading and may include a covering or coating with tissue or an expanding hydrophilic material. The orthopedic device delivery system can include a loading device with a channel for storing the orthopedic device in a non-straightened configuration and orienting the orthopedic device in the proper implantation orientation. The orthopedic device can be advanced or retrieved through the loading device with a knob and/or a flexible plunger. | 10-16-2008 |
| 20090005871 | SUTURE-BASED ORTHOPEDIC JOINT DEVICES - Devices and treatments for various joint conditions include a resilient elongate orthopedic device inserted into a joint space using a suture. The suture is passed through the joint space and used to pull the orthopedic device into the joint space. The suture may be using a percutaneously inserted needle or other type of needle-based delivery instrument. The resilient elongate orthopedic device may be restrained to a reduced profile that permits minimally invasive implantation, but assume an enlarged profile when positioned at an implantation site. | 01-01-2009 |
| 20090012612 | DEVICES AND METHODS FOR PUSH-DELIVERY OF IMPLANTS - Devices and treatments for a joint include a resilient elongate orthopedic device inserted into a joint space using a delivery instrument. The orthopedic device is housed in a delivery cavity of the delivery instrument delivered to an implantation site using a push mechanism. The delivery instrument optionally comprises a guide or tongue structure to facilitate positioning of the delivery instrument about the implantation site. | 01-08-2009 |
| 20090012617 | SUTURE-BASED ORTHOPEDIC JOINT DEVICE DELIVERY METHODS - Devices and treatments for various joint conditions include a resilient elongate orthopedic device inserted into a joint space using a suture. The suture is passed through the joint space and used to pull the orthopedic device into the joint space. The suture may be using a percutaneously inserted needle or other type of needle-based delivery instrument. The resilient elongate orthopedic device may be restrained to a reduced profile that permits minimally invasive implantation, but assume an enlarged profile when positioned at an implantation site. | 01-08-2009 |
| 20100168864 | TENSIONED DELIVERY OF ORTHOPEDIC JOINT DEVICE - Devices and treatments for various joint conditions include a resilient elongate orthopedic device inserted into a joint space using a suture. The suture is passed through the joint space and used to pull the orthopedic device into the joint space. The suture may be using a percutaneously inserted needle or other type of needle-based delivery instrument. The resilient elongate orthopedic device may be restrained to a reduced profile that permits minimally invasive implantation, but assume an enlarged profile when positioned at an implantation site. To facilitate insertion of the orthopedic device through a minimally invasive or limited access procedure, a delivery system may be used to support and orient the orthopedic device during implantation. In some instances, the delivery system may also reduce the delivery profile of the device for insertion through a minimally invasive or limited access procedure. | 07-01-2010 |
| 20110029094 | RETRIEVAL OF ORTHOPEDIC JOINT DEVICE - Delivery and retrieval systems for delivering or retrieving a shape-changing percutaneously implantable orthopedic device joint prosthesis that can move between a generally arcuate configuration and a substantially straightened or slightly curved configuration. The orthopedic device can be delivered with a needle that is joint expanding, actuating, pivotable, or can include a balloon. The orthopedic device acts as a soft compliant bearing surface or cushion that minimizes the bone-on-bone wear from articulation and loading and may include a covering or coating with tissue or an expanding hydrophilic material. The orthopedic device delivery system can include a loading device with a channel for storing the orthopedic device in a non-straightened configuration and orienting the orthopedic device in the proper implantation orientation. The orthopedic device can be advanced or retrieved through the loading device with a knob and/or a flexible plunger. | 02-03-2011 |
| Patent application number | Description | Published |
|---|
| 20080248477 | Novel ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor - Novel ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST proteins, the invention further provides isolated ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST fusion proteins, antigenic peptides and anti-ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST antibodies. The invention also provides ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced and non-human transgenic animals in which an ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST gene has been introduced or disrupted. Diagnostic, screening and therapeutic methods utilizing compositions of the invention are also provided. | 10-09-2008 |
| 20100136010 | Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor - The invention provides isolated nucleic acids molecules, designated 27875, 22025, 27420, 16319, 55092 and 10218 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 27875, 22025, 27420, 16319, 55092 and 10218 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 27875, 22025, 27420, 16319, 55092 and 10218 gene has been introduced or disrupted. The invention still further provides isolated 27875, 22025, 27420, 17906, 16319, 55092 or 10218 proteins, fusion proteins, antigenic peptides and anti-27875, 22025, 27420, 17906, 16319, 55092 or 10218 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided. | 06-03-2010 |
| 20110020798 | Novel italy, LOR-2, strife, trash, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor - Novel ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST proteins, the invention further provides isolated ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST fusion proteins, antigenic peptides and anti-ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST antibodies. The invention also provides ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced and non-human transgenic animals in which an ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST gene has been introduced or disrupted. Diagnostic, screening and therapeutic methods utilizing compositions of the invention are also provided. | 01-27-2011 |
| Patent application number | Description | Published |
|---|
| 20100223644 | Program guide optimization system - A method and system of optimizing strings comprised in program guide data for transmission is described. The method includes sharing, in the program guide data, a plurality of strings, each string among the plurality of strings including a shared sorting key, implementing an order access of a sorted sharing index, wherein the program guide data and the shared sorting key are comprised in the same data storage structure. Related methods and apparatus are also described. | 09-02-2010 |
| 20100235860 | Headend modeling of data - A data modeling method for modeling data for an electronic program guide (EPG) at a broadcast headend is described. The method includes grouping receiver types according to a first set of characteristics associated with a receiver type, thereby producing a plurality of groups of receivers, assigning a bit-number to each group of receivers, providing EPG data, the EPG data including data for display at an EPG, the EPG data being included in a data fragment, evaluating the data fragment and the EPG data included therein according to at least one characteristic from a second set of characteristics, thereby producing a result, adding metadata to the data fragment, the metadata including a bit field including the assigned bit number, the bit number being determined in accordance with the result, the metadata being indicative of at least one characteristic from the first set of characteristics with which a data container and EPG data included therein are associated, and broadcasting the data fragment in the data container. Related methods and apparatus are also described. | 09-16-2010 |
| 20110126235 | Program guide optimization system - A method and system of optimizing strings comprised in program guide data for transmission is described. The method includes sharing, in the program guide data, a plurality of strings, each string among the plurality of strings including a shared sorting key, implementing an order access of a sorted sharing index, wherein the program guide data and the shared sorting key are comprised in the same data storage structure. Related methods and apparatus are also described. | 05-26-2011 |
| 20110231879 | Headend modeling of data - A data modeling method for modeling data for an electronic program guide (EPG) at a broadcast headend is described. The method includes grouping receiver types according to a first set of characteristics associated with a receiver type, thereby producing a plurality of groups of receivers, assigning a bit number to each group of receivers, providing EPG data, the EPG data including data for display at an EPG, the EPG data being included in a data fragment, evaluating the data fragment and the EPG data included therein according to at least one characteristic from a second set of characteristics, thereby producing a result, adding metadata to the data fragment, the metadata including a bit field including the assigned bit number, the bit number being determined in accordance with the result, the metadata being indicative of at least one characteristic from the first set of characteristics with which a data container and EPG data included therein are associated, and broadcasting the data fragment in the data container. Related methods and apparatus are also described. | 09-22-2011 |
| Patent application number | Description | Published |
|---|
| 20100029734 | METHODS FOR BREAST CANCER SCREENING AND TREATMENT - A method for selecting a breast cancer patient for therapy with an agent that reduces production of angiotensin II, for example an ACE inhibitor or renin inhibitor, comprises (a) determining whether the cancer comprises a tumor that is estrogen receptor positive (ER+) and (b) selecting the patient for such therapy only if the cancer is determined to comprise an ER+ tumor. A method for treating breast cancer in a patient further comprises (c) administering to the patient, if so selected, an agent that reduces production of angiotensin II, for example an ACE inhibitor or renin inhibitor. A method for treating a breast tumor in a patient having SERM-resistant ER+ breast cancer comprises administering to the patient an agent that reduces production of angiotensin II, for example an ACE inhibitor or renin inhibitor. A therapeutic combination useful in treatment of a breast tumor comprises an agent that reduces production of angiotensin II, for example an ACE inhibitor or renin inhibitor, and a second agent that comprises (a) an aromatase inhibitor or (b) an estrogen receptor modulator or antagonist. | 02-04-2010 |
| 20100069400 | METHODS FOR TREATING INFLAMMATION AND RELATED CONDITIONS - A method for treating an inflammatory condition or immune disorder comprises administering to a subject having such a condition or disorder a therapeutically effective amount of at least one compound selected from irindalone, physiologically active enantiomers thereof, and pharmaceutically acceptable salts thereof. The invention further provides a method for elevating levels of anti-inflammatory cytokines such as IL-10 and IL-13 while inhibiting expression of pro-inflammatory cytokines. A pharmaceutical composition, useful for example in topical treatment of psoriasis, comprises a therapeutically effective amount of at least one compound selected from irindalone, physiologically active enantiomers thereof, and pharmaceutically acceptable salts thereof, in a vehicle comprising at least one pharmaceutically acceptable excipient, the vehicle being adapted for topical administration to skin of a subject. | 03-18-2010 |
| 20100105746 | METHOD FOR TREATING METABOLIC DISEASES - A method for treating a condition of low metabolic rate, dyslipidemia, excess adiposity and/or insulin resistance, or a disease or syndrome characterized by one or more of said conditions in a subject, comprises administering to the subject a therapeutically effective amount of romazarit or a pharmaceutically acceptable salt, ester or prodrug thereof. | 04-29-2010 |
| 20110171205 | NOVEL 15571, 2465, 14266, 2882, 52871, 8203 AND 16852 MOLECULES AND USES THEREFOR - The invention provides isolated nucleic acids molecules, designated 15571, 2465, 14266, 2882, 52871, 8203 or 16852 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 15571, 2465, 14266, 2882, 52871, 8203 or 16852 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 15571, 2465, 14266, 2882, 52871, 8203 or 16852 gene has been introduced or disrupted. The invention still further provides isolated 15571, 2465, 14266, 2882, 52871, 8203 or 16852 proteins, fusion proteins, antigenic peptides and anti-15571, 2465, 14266, 2882, 52871, 8203 or 16852 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided. | 07-14-2011 |
